# Travere Therapeutics, Inc.: Form 8-K, filed Mar 17, 2025

- Company: [Travere Therapeutics, Inc.](/companies/tvtx.md) (CIK 1438533)
- Form: 8-K
- Filed: 2025-03-17
- Accepted by EDGAR: Mar 17, 2025, 20:57 ET
- Period: 2025-03-17
- Accession: 0001438533-25-000012
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1438533/000143853325000012/tvtx-20250317.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1438533/000143853325000012/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1438533/000143853325000012/tvtx-20250317.htm

Filed Mar 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001438533-25-000012. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.